Find Your Script
MAY 25, 2022
Are you a student entering pharmacy school? In this video, I’ll talk about my 4 steps to have success in pharmacy school. Stay until the end for my most important step. Watch & Subscribe on our YouTube Channel ! [link]. Hi, I’m Dr. Jessica Louie and I’m an Associate Professor, Board-Certified Critical Care Pharmacist and entrepreneur. I help people find meaning beyond a job title and let go of burnout.
pharmaphorum
MAY 25, 2022
US pharma giant Pfizer has said it will sell some of its patented medicines at non-profit prices to 45 of the world’s poorest countries – including new launches. The initiative will focus on infectious diseases, cancer, inflammation, rare diseases and women’s health, and will include its BioNTech-partnered COVID-19 vaccine Comirnaty as well as oral antiviral therapy Paxlovid (nirmatrelvir/ritonavir).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fossil Remedies
MAY 25, 2022
Are you going to launch a new business by partnering with a new PCD Pharma Company ? Or do you want to expand your business by adding one more company? In both situations, you should be careful and selective while choosing a company. There are several companies around when you search for it. But it is always good to associate with the best one. Why should you prefer the best company?
pharmaphorum
MAY 25, 2022
The move to online international meetings has left pharma companies with uncertainty around contact compliance. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. Since COVID-19 reared its head more than two years ago, the traditional hustle and bustle of in-person annual congresses have largely been consigned to the history books.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
MAY 25, 2022
Northway Biotech, a contract development and manufacturing organization (CDMO) based out of Vilnius, Lithuania, is set to open a facility in Boston, US.
pharmaphorum
MAY 25, 2022
Around 100 patients in England and Wales with triple negative breast cancer (TNBC) that has spread to other parts of the body could soon access treatment with Merck & Co/MSD’s Keytruda, on the recommendation of cost-effectiveness agency NICE. The health technology assessment (HTA) body has published draft guidance supporting routine NHS use of Keytruda (pembrolizumab) along with chemotherapy in patient with metastatic TNBC whose tumours express the biomarker PD-L1 with a combine positi
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
MAY 25, 2022
Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of Arena Pharmaceuticals’ etrasimod in ulcerative colitis (UC) when it acquired the company earlier this year, and the gamble seems to have paid off. Yesterday, the company reported the results of the two trials of the S1P receptor modulator in patients with moderately-to-severely active UC at the Digestive Disease Week congress, with the data suggesting it could mount a strong challenge against rival Zeposia (ozanimod)
Outsourcing Pharma
MAY 25, 2022
Michelle Keefe, formerly the president of medical affairs and commercial solutions, joined the company in 2017; she also had spent 20 years working for Pfizer.
pharmaphorum
MAY 25, 2022
Roivant group company Dermavant has made the transition to a commercial-stage company after getting FDA approval for Vtama, a drug for psoriasis that it claims could be a game-changer in the treatment of the skin disorder. Vtama (tapinarof) – originally developed by GlaxoSmithKline – is a first-in-class, once-daily topical therapeutic aryl hydrocarbon receptor modulating agent (TAMA) and has been approved by the US regulator with a broad label spanning mild, moderate, and severe psoriasis and an
Outsourcing Pharma
MAY 25, 2022
The DATAcc has released a collection of open-access resources that are intended to help users build inclusivity into digital health measurement products.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Med Ed 101
MAY 25, 2022
On May 13, 2022, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s Mounjaro (tirzepatide), a once-weekly injection for the treatment of type 2 diabetes mellitus (T2DM). Pathophysiology of Type 2 Diabetes Mellitus Incretins are the hormones that are released by the body in response to a meal. There are two key […]. The post Tirzepatide Clinical Breakdown appeared first on Med Ed 101.
Pharma Times
MAY 25, 2022
Technology is already being used in clinical trials of new treatments for Alzheimer’s and new studies will provide additional validation
pharmaphorum
MAY 25, 2022
Most pharma and biopharma executives agree the patient voice should be at the centre of everything they do. But for many, it is a prospect that remains much easier said than done. A lack of defined processes for the collection and sharing of insights across the drug development cycle has hampered the industry’s good intentions and, in some cases, turned engagement into an empty box-ticking exercise.
pharmaphorum
MAY 25, 2022
After more than six years of development, Angle has scored an FDA approval for Parsortix as a diagnostic for metastatic breast cancer – the first ever in the US for a device used to detect cancer by harvesting cells from a patient blood sample. In a statement , the UK medical device firm said its “liquid biopsy” approach “offers the prospect of a new era of personalised cancer care” and moves it closer to positioning Parsortix as a go-to technology for assessing cancer st
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
MAY 25, 2022
Shares in US biotech Verrica Pharma lost half their value today after the FDA declined to approve its candidate treatment for viral skin infection molluscum contagiosum for a third time. The problems outlined in the US regulator’s complete response letter (CRL) for VP-102 centre around contract manufacturing organisation (CMO) Sterling Pharmaceuticals Services, which is producing VP-102 for Verrica.
Expert insights. Personalized for you.
130 
Let's personalize your content